TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
This Quarter Return
+11.93%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.58B
AUM Growth
+$2.58B
(+9.9%)
Cap. Flow
+$15.1M
Cap. Flow
% of AUM
0.59%
Top 10 Holdings %
Top 10 Hldgs %
43.75%
Holding
150
New
7
Increased
20
Reduced
25
Closed
10
Top Buys
| 1 |
Amgen
AMGN
|
$59.6M |
| 2 |
Johnson & Johnson
JNJ
|
$33.8M |
| 3 |
Viatris
VTRS
|
$16.2M |
| 4 |
McKesson
MCK
|
$14.5M |
| 5 |
Thermo Fisher Scientific
TMO
|
$13.3M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
$29.5M |
| 2 |
MDCO
Medicines Co
MDCO
|
$26.2M |
| 3 |
Incyte
INCY
|
$25M |
| 4 |
Abbott
ABT
|
$19.1M |
| 5 |
Centene
CNC
|
$18.2M |
Sector Composition
| 1 | Healthcare | 91.08% |
| 2 | Real Estate | 3.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Cencora
COR
$56.5B
| $29.3M | 1.13% |
330,687
| – | – |
|
27
iShares Biotechnology ETF
IBB
$5.69B
| $22.9M | 0.89% |
77,970
+20,300
| +35% | +$5.95M |
|
28
Idexx Laboratories
IDXX
$51.8B
| $20.5M | 0.79% |
132,352
| – | – |
|
29
Neurocrine Biosciences
NBIX
$13.8B
| $19.3M | 0.75% |
446,074
+54,205
| +14% | +$2.35M |
|
30
Novartis
NVS
$245B
| $18.5M | 0.72% |
248,800
| – | – |
|
31
Molina Healthcare
MOH
$9.8B
| $18.4M | 0.71% |
402,541
| – | – |
|
|
32
McKesson
MCK
$85.4B
| $16.8M | 0.65% |
113,100
+98,100
| +654% | +$14.5M |
|
33
SPDR S&P Biotech ETF
XBI
$5.25B
| $15.7M | 0.61% |
226,460
+47,460
| +27% | +$3.29M |
|
34
Sabra Healthcare REIT
SBRA
$4.58B
| $15.4M | 0.6% |
550,990
| – | – |
|
35
Sarepta Therapeutics
SRPT
$1.9B
| $15.1M | 0.59% |
511,600
+45,300
| +10% | +$1.34M |
|
36
GSK
GSK
$78.5B
| $15.1M | 0.59% |
359,000
| – | – |
|
37
Omega Healthcare
OHI
$12.6B
| $15.1M | 0.59% |
458,616
| – | – |
|
|
PRTK
38
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $14.7M | 0.57% |
762,581
| – | – |
|
39
AstraZeneca
AZN
$249B
| $14.4M | 0.56% |
463,800
| – | – |
|
40
Sanofi
SNY
$121B
| $13.8M | 0.54% |
305,000
| – | – |
|
|
DHC
41
Diversified Healthcare Trust
DHC
$920M
| $13.1M | 0.51% |
646,554
| – | – |
|
42
Medical Properties Trust
MPW
$2.65B
| $13M | 0.5% |
1,007,717
| – | – |
|
|
WELL.PRI
43
DELISTED
Welltower Inc.
WELL.PRI
| $12.6M | 0.49% |
200,000
| – | – |
|
44
Alnylam Pharmaceuticals
ALNY
$58.5B
| $12.5M | 0.48% |
243,995
| – | – |
|
45
Zimmer Biomet
ZBH
$21B
| $12.5M | 0.48% |
102,300
| – | – |
|
46
Cigna
CI
$80.3B
| $12.3M | 0.48% |
83,900
-2,500
| -3% | -$366K |
|
47
Exelixis
EXEL
$10.1B
| $12M | 0.46% |
551,647
| – | – |
|
48
Merus
MRUS
$5.01B
| $11.7M | 0.45% |
479,150
| – | – |
|
49
Ventas
VTR
$30.9B
| $11.4M | 0.44% |
175,991
| – | – |
|
50
Charles River Laboratories
CRL
$8.04B
| $11.4M | 0.44% |
127,100
-500
| -0.4% | -$45K |
|